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Abstract
The management of the obese patient in intensive care is fraught
with difficulty, or so conventional wisdom would have us believe.
Two recent studies add to the growing evidence that the obese
patient is not significantly disadvantaged in terms of outcome
following intensive care admission. Another study highlights the
increasing burden of end-stage renal disease on intensive care unit
resources with some interesting results. And there is more on
citrate, the new anticoagulant!
Thou seest I have more flesh than another
man, and therefore more frailty.
(William Shakespeare)
The imbalance between the haves and the have nots is no
more striking than when one considers nutrition. Obesity is an
increasing problem in most of the western world with
approaching 300 million people being classified as obese,
whereas starvation affects almost one-half of the global
population. Indeed, the obesity epidemic is highlighted here
in the United Kingdom, where over the period between 1980
and 1997 the obesity rates in adults trebled [1]. As a
consequence we are often faced with the management of
such patients in our intensive care units (ICUs) and their
inherent problems. Obese patients are viewed as more
complex to manage for a variety of reasons: they are difficult
to intubate, difficult to ventilate, difficult to wean, difficult to
move – the list goes on. And on. But are these
generalisations justified in the majority of cases? Two studies
reported recently in Intensive Care Medicine add more
weight to the arguments against such views [2,3].
In the study by Sakr and colleagues, the European obser-
vational Sepsis Occurrence in Acutely Ill Patients study
database was interrogated to examine the effect of body
mass index (BMI) on morbidity and mortality outcomes [2].
Patients were stratified as underweight (BMI <18.5), normal
weight (BMI 18.5 to 24.9), overweight (BMI 25 to 29.9),
obese (BMI 30 to 39.9) and very obese (BMI ≥40). BMI data
were available from 91% of the cohort, with 53.9% being
classed as overweight or greater and 2.8% classed as very
obese. The results make interesting reading. There was no
association between increased mortality and obesity. There
was, however, an increase in morbidity with a trend towards
longer length of stay, both in the ICU and in the hospital,
between the normal weight groups and the very obese
patients. Similarly, those patients with higher BMI showed an
increase in ICU-acquired infections. The authors do point out
the limitations of this study, not least the inconsistencies in
measurement of height and weight (a simple yet seemingly
impossible task to do well in the ICU) and the paucity of
detailed data relating to mechanical ventilation parameters,
including the use of tracheotomies [2].
Frat and colleagues have examined the effect of obesity on
mechanically ventilated patients prospectively, which makes
their study almost unique [3]. Patients were classified into
two groups, severely obese (BMI ≥35) or normal (BMI <30).
Again, no differences in mortality were observed – although
intubation was more difficult and stridor on extubation was a
more common complication in the severly obese patients. So
where does this leave us? As doctors we are not immune
from society’s prejudice against obese individuals, and some
intensivists may still share Shakespeare’s view – but in the
light of these recent studies, perhaps it is time for a rethink.
Indeed, when one considers the BMI and ICU outcome, it is
the malnourished patients (BMI <18.5) who fare worse, not
the obese patients – a thought-provoking point made in the
accompanying editorial [4,5].
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One conclusion from these studies is clear: obese patients
do consume considerable resources in common with another
group of patients – those requiring end-stage renal support.
In keeping with, and probably intimately linked to, obesity, the
need for end-stage renal support is increasing – with some
sources predicting a doubling in incidence over the next
decade [6]. Unsurprisingly, ICU admissions of patients with
end-stage renal disease are increasing, and a recent UK
study revealed that 1.3% of all patients admitted to the ICU
were on end-stage renal support [7].
A recent study from the Swedish Intensive Care Nephrology
Group (SWING) investigators examined both short-term and
long-term outcomes of patients admitted to the ICU already
on end-stage renal support in Sweden [8]. Interestingly the
study showed that the 90-day mortality for patients with end-
stage renal disease admitted to the ICU was 42%, compared
with 50% of patients with acute kidney injury requiring renal
replacement therapy. No consideration is given for severity of
illness scoring, however, and it may be that this reflects a
lower threshold for admission of these patients to the ICU.
The long-term outcomes of the patients admitted to the ICU
were compared with end-stage renal disease patients not
requiring ICU care, and unsurprisingly an increase in long-
term mortality being associated with heart failure and older
age was found. Short-term outcomes (90-day mortality) were
associated with the classical cardiovascular risk factors,
including diabetes, heart failure and, again, age. This exhibits
a similar risk profile to those identified in preoperative studies
on end-stage renal patients – in that those patients with
limited cardiac reserve fare less well.
Continuing the renal theme, Critical Care Medicine also
carries yet another paper examining the role of regional,
citrate-based anticoagulation for continuous venovenous
haemodialfiltration [9]. In keeping with many studies, the
outlook from acute kidney injury in this cohort was bleak with
a hospital mortality of 59% from a cohort of 143 patients. The
degree of resulting dialysis dependence was also high, with
one in five survivors requiring long-term renal replacement
therapy. This is a retrospective noncontrol-based study.
Several positive conclusions can, however, be drawn from
the study. Firstly, the circuit survival time using this regional-
based system was acceptable, the median time being some
72 hours. Secondly, the delivered dose was in excess of
35 ml/kg/hour, illustrating that citrate systems do not
adversely affect dose delivery. In keeping with other studies,
subjects with hepatic impairment coped with the citrate load
poorly. Is there any benefit from using citrate anticoagulation?
The answer to that question remains to be seen and, given
the current studies in place, we shall not have to wait long for
the answer.
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